T
TECH icon

TOBAM’s Bio-Techne TECH Stock Holding History

TOBAM’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-652
Closed -$54K – 416
2022
Q4 		$54K Sell
652
-504
-44% -$40K ﹤0.01% 340
2022
Q3 		$82K Buy
1,156
+420
+57% +$36.3K 0.01% 307
2022
Q2 		$64K Sell
736
-40
-5% -$3.75K ﹤0.01% 353
2022
Q1 		$84K Buy
776
+164
+27% +$16.9K ﹤0.01% 327
2021
Q4 		$79K Hold
612
– – ﹤0.01% 294
2021
Q3 		$74K Buy
612
+336
+122% +$40.9K ﹤0.01% 309
2021
Q2 		$31K Sell
276
-348
-56% -$36.6K ﹤0.01% 421
2021
Q1 		$60K Hold
624
– – ﹤0.01% 308
2020
Q4 		$50K Hold
624
– – ﹤0.01% 325
2020
Q3 		$39K Buy
+624
New +$40.6K ﹤0.01% 331

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

TOBAM's TECH Position: Q1 2023 in Review

TOBAM sold out of Bio-Techne (TECH) in Q1 2023, closing a stake of 652 shares — an estimated $54K sold.

TOBAM first reported a position in TECH in Q3 2020 and held it in 10 quarters. The position peaked at $84K in Q1 2022. 550 funds tracked by Wall St. Rank hold TECH as of Q1 2023.

  • TOBAM reported no remaining Bio-Techne position as of Q1 2023 after selling out during the quarter.
  • TOBAM sold 652 Bio-Techne shares in Q1 2023, an estimated $54K.
  • TOBAM first reported a position in Bio-Techne in Q3 2020 and held it in 10 quarters.
  • TOBAM's Bio-Techne position peaked at $84K in Q1 2022.
  • 550 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2023.

Based on TOBAM's 13F filing for Q1 2023, filed 3 May 2023.